AG
RUBY
Artal Group’s Rubius Therapeutics, Inc RUBY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,042,666
| Closed | -$44K | – | 137 |
|
|
2023
Q1 | $44K | Hold |
2,042,666
| – | – | ﹤0.01% | 117 |
|
|
2022
Q4 | $357K | Hold |
2,042,666
| – | – | 0.02% | 114 |
|
|
2022
Q3 | $886K | Sell |
2,042,666
-1,658,914
| -45% | -$720K | 0.04% | 114 |
|
|
2022
Q2 | $3.15M | Hold |
3,701,580
| – | – | 0.17% | 78 |
|
|
2022
Q1 | $20.4M | Hold |
3,701,580
| – | – | 0.85% | 27 |
|
|
2021
Q4 | $35.8M | Sell |
3,701,580
-454,045
| -11% | -$4.4M | 0.97% | 25 |
|
|
2021
Q3 | $74.3M | Sell |
4,155,625
-478,166
| -10% | -$8.55M | 1.66% | 12 |
|
|
2021
Q2 | $113M | Sell |
4,633,791
-250,000
| -5% | -$6.1M | 2.3% | 10 |
|
|
2021
Q1 | $129M | Buy |
4,883,791
+1,104,878
| +29% | +$29.3M | 2.29% | 6 |
|
|
2020
Q4 | $28.7M | Hold |
3,778,913
| – | – | 0.62% | 39 |
|
|
2020
Q3 | $18.9M | Sell |
3,778,913
-73,428
| -2% | -$368K | 0.46% | 38 |
|
|
2020
Q2 | $23M | Sell |
3,852,341
-31,450
| -0.8% | -$188K | 0.64% | 31 |
|
|
2020
Q1 | $17.3M | Buy |
3,883,791
+1,050,000
| +37% | +$4.67M | 0.73% | 27 |
|
|
2019
Q4 | $26.9M | Hold |
2,833,791
| – | – | 1.04% | 20 |
|
|
2019
Q3 | $22.2M | Hold |
2,833,791
| – | – | 0.89% | 16 |
|
|
2019
Q2 | $44.6M | Sell |
2,833,791
-75,000
| -3% | -$1.18M | 1.8% | 11 |
|
|
2019
Q1 | $52.7M | Hold |
2,908,791
| – | – | 2.15% | 9 |
|
|
2018
Q4 | $46.8M | Hold |
2,908,791
| – | – | 1.73% | 7 |
|
|
2018
Q3 | $69.8M | Buy |
+2,908,791
| New | +$69.8M | 1.82% | 4 |
|